Alessandro La Jolla Sette - Vaccines

Author Information

Alessandro D. Sette is affiliated with the Division of Vaccine Discovery at the La Jolla Institute for Immunology, located in La Jolla, California, USA. His research primarily focuses on immunology, with a particular emphasis on vaccine discovery and development.

Research Contributions

Alessandro D. Sette has made significant contributions to our understanding of immune responses to infectious diseases, particularly SARS-CoV-2. His research in 2022 includes studies on T cell responses to SARS-CoV-2 variants, immune protection against these variants, and immunological memory induced by COVID-19 vaccines. Notable works include investigations into T cell responses in children with multisystem inflammatory syndrome, the cross-recognition of Omicron variants by T cells, and the assessment of immunological memory to common cold coronaviruses over three years.

Aliases

Alessandro D. Sette is also known by several aliases, including Alessandro La Jolla Sette, Alessandro D Sette, A. Sette, and Alessandro Sette.

Publication and Citation Metrics

Citation Count	94,567
H-index	158
Paper Count	1,259

Publications:

Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19

DOI: 10.1172/jci.insight.155145

Year: 2022

Defining the risk of SARS-CoV-2 variants on immune protection.

DOI: 10.1038/s41586-022-04690-5

Year: 2022

T cell responses to SARS-CoV-2 spike cross-recognize Omicron

DOI: 10.1038/s41586-022-04460-3

Year: 2022

Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues

DOI: 10.1101/2022.01.06.475282

Year: 2022

Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions

DOI: 10.1016/j.isci.2022.103850

Year: 2022

Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines

DOI: 10.1101/2022.03.15.484542

Year: 2022

SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron

DOI: 10.1016/j.cell.2022.01.015

Year: 2022

Antigenic determinants of SARS-CoV-2-specific CD4+ T cell lines reveals M protein-driven dysregulation of interferon signaling

DOI: 10.1101/2022.01.20.22269491

Year: 2022

Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period

DOI: 10.1101/2022.03.01.482548

Year: 2022

Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

DOI: 10.1016/j.cell.2022.01.027

Year: 2022

What Mechanisms Might Cause These Complications?

What Types of Malaria Vaccines are Being Developed?

Who Can Report Adverse Events?

What are Live Attenuated Vaccines?

Which Vaccines Are Recommended for Individuals with Cardiovascular Disease?

What are Some Key Achievements of CISA?

How Are Vaccines Administered?

How is Vaccination Coverage Measured?

Why Continue Vaccination?

What Are the Consequences of Missing Vaccine Timelines?

Partnered Content Networks

Relevant Topics